Pharmacological Management of Spinal Cord Injuries

Introduction[edit | edit source]

Every year there are around 17,700 new cases of spinal cord injuries in the United States of America, most commonly from vehicular accidents and falls[1]. The primary injury in these events is a compression, tear, or dissection of the spinal cord in the spinal column. Often, there is a secondary injury to the peripheral nerves off the dorsal and ventral roots, an inflammatory response, and subsequent axonal degeneration[2]. These injuries carry a high price for care, as lifetime costs can range from $1.6 to $4.9 million if injury occurs at age 25. Life expectancy has not improved substantially since the 1980s, and the leading causes of death are pneumonia and septicemia[1].

Opioids[edit | edit source]

Benzodiazepines[edit | edit source]

Gabapentin[edit | edit source]

Baclofen[edit | edit source]

Corticosteroids[edit | edit source]

Overall Implications for Physical Therapy[edit | edit source]